The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma

Pediatric Blood & Cancer
Arnold C PaulinoB-Chen Wen

Abstract

To determine the value of postoperative radiotherapy (RT) in the management of nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) of childhood. From 1964 to 2000, 62 children with a median age of 14 years were seen at the University of Iowa and underwent a wide local excision for non-metastatic NRSTS. Tumors were high grade in 36 (58%) and >5 cm in 24 (39%). Margins of resection were negative (Group I) in 37 (60%) and positive (Group II) in 25 (40%). Postoperative RT was delivered to 20 patients (32%); eight of 37 (22%) Group I and 12 of 25 (48%) Group II children received postoperative RT. Chemotherapy was employed in 19 patients (31%). Median follow-up was 9.6 years. The 5- and 10-year overall survival rates for Group I were 69 and 63% and for Group II were 66 and 60%. The 5- and 10-year local control rate was 66%. On multivariate analysis, size of tumor (P < 0.001) and postoperative RT (P = 0.017) were prognostic factors for local control. All 13 Group I children with low grade, </=5 cm tumors were locally controlled without RT. For Group II patients, 2- and 5-year local control rates were 92 and 82% with postoperative RT and 51 and 43% for no RT (P = 0.0426). Local control was improved by the addition of postoperative RT in tu...Continue Reading

References

Jan 1, 1979·Medical and Pediatric Oncology·R B RaneyJ Chatten
Feb 1, 1992·Journal of Pediatric Surgery·P DillonA Salzberg
Nov 1, 1992·Archives of Surgery·R J GeerM F Brennan
Jan 11, 1992·Medical and Pediatric Oncology·A HayaniD J Fernbach
Jul 1, 1991·The Journal of Bone and Joint Surgery. British Volume·A RydholmN O Berg
Jan 15, 1988·Cancer·H M MaurerJ Ortega
Jan 1, 1982·Medical and Pediatric Oncology·G PastoreS E Sallan
Jul 1, 1993·Journal of Surgical Oncology·D M McCoyT K Das Gupta
Mar 1, 1996·Annals of Surgical Oncology·B R CoferE S Wiener
Jun 1, 1997·The Journal of Bone and Joint Surgery. American Volume·C P GibbsM A Simon
Dec 5, 1997·The Journal of Pediatrics·K C MarcusN J Tarbell
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C YangS A Rosenberg
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C B PrattH Maurer
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L SpuntA S Pappo
May 20, 2000·Clinical Orthopaedics and Related Research·J E McGroryC M Rowland
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kaled M AlektiarMurray F Brennan
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mehmet Fatih OkcuBeverly Raney
Apr 2, 1966·British Medical Journal·B A Stoll, J T Andrews

❮ Previous
Next ❯

Citations

Jan 18, 2016·Bulletin du cancer·Ludovic MansuyNadège Corradini
May 10, 2011·International Journal of Radiation Oncology, Biology, Physics·Kristy B SmithRobert B Marcus
Aug 21, 2007·Surgical Oncology·Chan Hon Chui
Dec 3, 2015·Journal of Indian Association of Pediatric Surgeons·Sajid S Qureshi, Monica Bhagat
Apr 6, 2021·Pediatric Blood & Cancer·Sarah A MilgromStephanie Terezakis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.